Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 12: 608890, 2021.
Article in English | MEDLINE | ID: mdl-33767694

ABSTRACT

Human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) develops in 1-5% of HTLV-1-infected individuals. Previous studies by us and others have shown that the expression of negative immune checkpoint receptors (NCRs) is significantly increased on CD8 T cells in various chronic viral infections and are associated with poor anti-viral immunity. We have previously identified the differential expression of NCRs on CD8 T cells in blood from patients with HAM/TSP and in central nervous system (CNS) tissues of HTLV-1 infected humanized mice and defined the association with neurological complications. In this study, we determined the co-expression patterns of several key NCRs (PD-1, TIGIT, TIM-3, and LAG-3) and their cognate ligands in HTLV-1 infection and assessed how combination strategies targeting these pathways would impact HTLV-1-specific CD8 T-cell effector functions as an approach to reduce CNS disease outcomes. We found that global CD8 T cells from HAM/TSP patients co-express multiple NCRs at significantly higher frequencies than asymptomatic carriers (AC). Moreover, NCR ligands (PVR and PD-LI) on both plasmacytoid and myeloid dendritic cells were also expressed at higher frequencies in HAM/TSP compared to AC. In both AC and HAM/TSP subjects, combination dual PD-L1/TIGIT or triple PD-L1/TIGIT/TIM-3 blockade with monoclonal antibodies resulted in increases in intracellular cytokine expression in CD8 T cells after virus stimulation, particularly CD107a, a marker of degranulation, and TNF-α, a key cytokine that can directly inhibit viral replication. Interestingly, almost all blockade combinations resulted in reduced IL-2+ HTLV-1-specific CD8 T cell frequencies in HAM/TSP subjects, but not in AC. These results define a novel combinatorial NCR immunotherapeutic blockade strategy to reduce HAM/TSP disease burden.


Subject(s)
Anti-Retroviral Agents/pharmacology , HTLV-I Infections/genetics , HTLV-I Infections/immunology , Human T-lymphotropic virus 1/drug effects , Human T-lymphotropic virus 1/immunology , Immune Checkpoint Inhibitors/pharmacology , Adult , Anti-Retroviral Agents/therapeutic use , Biomarkers , Clinical Decision-Making , Cytokines , Disease Management , Drug Therapy, Combination , Female , Gene Expression Regulation/drug effects , HTLV-I Infections/drug therapy , HTLV-I Infections/virology , Host-Pathogen Interactions/immunology , Humans , Immune Checkpoint Inhibitors/therapeutic use , Immune Checkpoint Proteins/genetics , Immune Checkpoint Proteins/metabolism , Immunologic Memory , Immunophenotyping , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Lymphocyte Count , Male , Middle Aged , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Treatment Outcome , Viral Load
2.
Cell Rep ; 22(7): 1824-1834, 2018 02 13.
Article in English | MEDLINE | ID: mdl-29444434

ABSTRACT

Helminth infection is known for generating large amounts of poly-specific IgE. Here we demonstrate that innate-like B1 cells are responsible for this IgE production during infection with the nematode parasites Nippostrongylus brasiliensis and Heligmosomoides polygyrus bakeri. In vitro analysis of B1 cell immunoglobulin class switch recombination to IgE demonstrated a requirement for anti-CD40 and IL-4 that was further enhanced when IL-5 was added or when the B1 source was helminth infected mice. An IL-25-induced upregulation of IgE in B1 cells was also demonstrated. In T cell-reconstituted RAG1-/- mice, N. brasiliensis clearance was enhanced with the addition of B2 cells in an IgE-dependent manner. This enhanced clearance was impeded by reconstitution with IgE sufficient B1 cells. Mucosal mast cells mediated the B2 cell enhancement of clearance in the absence of B1 cells. The data support B1 cell IgE secretion as a regulatory response exploited by the helminth.


Subject(s)
B-Lymphocytes/immunology , Immunoglobulin E/metabolism , Mast Cells/metabolism , Parasites/physiology , Strongylida Infections/immunology , Animals , Antibody Formation/immunology , Cell Degranulation , Epitopes/immunology , Immunization , Interleukins/metabolism , Mast Cells/physiology , Mice , Nematospiroides dubius/physiology , Nippostrongylus/physiology , T-Lymphocytes/immunology
3.
J Foot Ankle Surg ; 49(4): 398.e1-4, 2010.
Article in English | MEDLINE | ID: mdl-20537566

ABSTRACT

Synovial sarcoma arising in the foot is a rare finding. We report a 64-year-old female with synovial sarcoma involving the calcaneus and central plantar compartment. The patient presented with a 2-year history of painful heel with soft tissue mass presentation 21 months after initial pain. We performed an incisional biopsy with frozen section; histopathology was consistent with synovial sarcoma.


Subject(s)
Calcaneus/pathology , Sarcoma, Synovial/diagnosis , Soft Tissue Neoplasms/diagnosis , Analgesics/administration & dosage , Biopsy , Female , Foot , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Magnetic Resonance Imaging , Middle Aged , Neoplasm Invasiveness , Sarcoma, Synovial/drug therapy , Soft Tissue Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...